Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease.
Claire GordonDesmond CheeBenjamin HamiltonNeel M HeerasingPeter HendyNeil ChanchlaniSimeng LinEmma WesleyIan R DanielsNishanthi SilvaMelanie OsborneNicholas Alexander KennedyJames R GoodhandTariq AhmadPublished in: Alimentary pharmacology & therapeutics (2020)
The incidence of IBD-associated CRC has remained static. Two-thirds of patients eligible for colonoscopic surveillance had missed opportunities to diagnose CRC. Surveillance programmes without comprehensive and fully integrated recall systems across primary and secondary care are set to fail.